Remove Analysis Remove Exercises Remove Healthcare Remove Security
article thumbnail

US govt agencies share details of the China-linked espionage malware Taidoor

Security Affairs

The FBI, the Cybersecurity and Infrastructure Security Agency (CISA), and the Department of Defense (DoD) released information on a RAT variant, dubbed TAIDOOR, used by China-linked hackers in cyber espionage campaigns targeting governments, corporations, and think tanks. ” reads Malware Analysis Report MAR-10292089-1.v1.

article thumbnail

Regulatory Update: NAIC Summer 2020 National Meeting

Data Matters

The current draft of the FAQ document addresses topics such as general background, the intersection of state insurance regulation and federal securities law regulation, how to satisfy the best interest standard of conduct, and insurer supervision and training requirements. Revisions to Model 440.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

Determining the scope of each of these exemptions and how they apply to a company will require careful analysis. Revisit determinations of what data and portions of a company are subject to the CMIA and re-evaluate this analysis in light of the CCPA. Health care providers subject to CMIA. Clinical trials subject to the Common Rule.

Privacy 45
article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

Determining the scope of each of these exemptions and how they apply to a company will require careful analysis. Revisit determinations of what data and portions of a company are subject to the CMIA and re-evaluate this analysis in light of the CCPA. Health care providers subject to CMIA. Clinical trials subject to the Common Rule.

Privacy 40
article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

Determining the scope of each of these exemptions and how they apply to a company will require careful analysis. Revisit determinations of what data and portions of a company are subject to the CMIA and re-evaluate this analysis in light of the CCPA. Health care providers subject to CMIA. Clinical trials subject to the Common Rule.

Privacy 40